Daelynn R. Buelow

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “BMX kinase mediates gilteritinib resistance inFLT3-mutated AML through microenvironmental factors”.

BMX kinase mediates gilteritinib resistance inFLT3-mutated AML through microenvironmental factors

Blood Advances(2022)10.1182/bloodadvances.2022007952

N/A

0.675DataRank · unranked

16 citations

Bhavana Bhatnagar, Shelley Orwick, Jae Yoon Jeon, Eric D. Eisenmann, Jack C. Stromatt +5 more

Gilteritinib-induced upregulation of S100A9 is mediated through BCL6 in acute myeloid leukemia

Blood Advances(2021)10.1182/bloodadvances.2021005614

N/A

0.471DataRank · unranked

11 citations

Jae Yoon Jeon, Zahra Talebi, Daelynn R. Buelow, Josie A. Silvaroli, Moray J. Campbell +4 more

A Phase 1b/2 Study of TP-0903 and Decitabine Targeting Mutant TP53 and/or Complex Karyotype in Patients with Untreated Acute Myeloid Leukemia ≥Age 60 Years

Cancer Research Communications(2025)10.1158/2767-9764.crc-25-0091

N/A

0.216DataRank · unranked

3 citations

Ronan Swords, Ying Huang, Shelley Orwick, Daelynn R. Buelow, Nicole Abbott +23 more

Framework of clonal mutations concurrent with WT1 mutations in adults with acute myeloid leukemia: Alliance for Clinical Trials in Oncology study

Blood Advances(2023)10.1182/bloodadvances.2023010482

N/A

0DataRank · unranked

2 citations

Jessica Kohlschmidt, Shelley Orwick, Daelynn R. Buelow, Sydney Fobare, Christopher C. Oakes +12 more

Prognostic, biological, and structural implications of FLT3-JMD point mutations in acute myeloid leukemia: an analysis of Alliance studies

Leukemia(2025)10.1038/s41375-024-02498-y

N/A

0DataRank · unranked

4 citations

Deedra Nicolet, Najla Alotaibi, Daelynn R. Buelow, Shelley Orwick, Charles T. Gregory +15 more

DNA Methylation‐Based Epigenetic Repression of SLC22A4 Promotes Resistance to Cytarabine in Acute Myeloid Leukemia

Clinical and Translational Science(2020)10.1111/cts.12861

N/A

0DataRank · unranked

26 citations

Jason T. Anderson, Stanley Pounds, Lei Shi, Jatinder K. Lamba, Shuiying Hu +5 more

Drug–Drug Interaction Liabilities with BTK Inhibitor TL-895

Cancer Research Communications(2025)10.1158/2767-9764.crc-25-0265

N/A

0DataRank · unranked

1 citations

Eman Ahmed, Thomas Drabison, Mahesh R. Nepal, Anika T. Chowdhury, Shelley Orwick +6 more

Gilteritinib Inhibits Glutamine Uptake and Utilization in FLT3-ITD–Positive AML

Molecular Cancer Therapeutics(2021)10.1158/1535-7163.mct-21-0071

N/A

0DataRank · unranked

45 citations

Xiyuan Lu, Zahra Talebi, Jae Yoon Jeon, Daelynn R. Buelow, Alice A. Gibson +13 more

TP-0903 Is Active in Preclinical Models of Acute Myeloid Leukemia with TP53 Mutation/Deletion

Cancers(2022)10.3390/cancers15010029

N/A

0DataRank · unranked

10 citations

Jack C. Stromatt, Sydney Fobare, Kevin M. Huang, Daelynn R. Buelow, Shelley Orwick +8 more